9999999997-19-005909.txt : 20190701
9999999997-19-005909.hdr.sgml : 20190701
20190701104353
ACCESSION NUMBER: 9999999997-19-005909
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20190701
DATE AS OF CHANGE: 20190701
ACTION DATE: 20190701
RECEIVED DATE: 20190701
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001023024
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 582301143
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 19931842
BUSINESS ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
BUSINESS PHONE: 2186343500
MAIL ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
FORMER COMPANY:
FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19991228
FORMER COMPANY:
FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991027
CT ORDER
1
filename1.pdf
begin 644 filename1
M)5!$1BTQ+C4-"B6UM;6U#0HQ(# @;V)J#0H\/"]4>7!E+T-A=&%L;V7!E+U!A9V5S+T-O=6YT(#$O2VED'0O26UA9V5"+TEM86=E0R]);6%G94E=(#X^+TUE9&EA0F]X6R P(# @-C$R
M(#2]#4R]$979I8V521T(^/B]486)S+U,O4W1R=6-T4&%R96YT
M)R566UOVS@2_AX@_X' ?I& A!5)
M42^+Q0*IDW1=;)*]U#TLL#T97K/HUU_9^^L)>S\[/WMW*YB0;+8Z/Q,L@K^"Y1&/9,S2
M*.-YS&;;\[.(?<4?'\[/_@I8^!\V^WA^=@.+V9-&3;,2I*.&19DFN
MN6C%O2%$C@C)!%=>0M2(D"3EVDM(/"!$ZHR+E"5:\=0(^7P?QL%T%EZJX":\
ME,$U^P2_Q,'5[ :_^]3;P]('9.3:%C6JCQ[01Z0)3S.6J-Q$ZR_8T&@R^0R:
M/4YG4_R%OJ%G[ HUOF8W?X9"!)/?Z-8=9"V.3A+KS4P1U:]0D-H473AWN'
M(;&"V.:V#J.&)$..3377X%B9O.;)Q[UC1YEE7.8V>/.#"9>G(?*)MN$73$8B
M=RU0"=?*7C!J43J2;T)Z)FTV%-]$\%@RG6>O2?OP>'WSR#Z$>?!XA8&ZGTWO
M,7HLO,R#R];2@@7-"28UBD71@K5X)3]@=:MT>KY
M#F.[A5C-G_'3$I[O\4%3/( 8AW+4N!3[*[77C
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M! J6VL\%4B6"S<,D*!DZXN5ETS,]#M 1H%-5LGVY0-?L
M7#O%$61=,F@#204W+_1
MOWO\5*-U<5!^Q6;ALLLD7!IC4;;2T#,E0Q'?45BS+.L"7%2MR)/L9;<,T^!;
M44&? 6ZHV5=HJK0_+6P0Z(Q7SA-A[X:QJ,I5L0@O,[*@;-,3A6T8!1$VA(!2
MP+:&V&&?5;5#AB_*]L-VWJ":M+AAR^_(7BA\LU] $KQA?Q+QU&BTVH&9U;;=
M>TU=Y.8[:KQ]G_X@E3W(;^R^G
M1^&PB;[9/RQU,&F Z#Q[Z%6,$OJ)3AY
MP=#-4%-40B^'HJ6'94,)7$-5P:CZA+ ?H727KDQ@$E/V;LC_PK\!N(^JYVFZI M#"8KYAM#E9ORK*.3PHS9."
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M1.0^' @\IEJ+G4=VG2+(2RF91E3%/MCN[L+"-NM=M?^*1^6UYOC0O:6Q
M&E][^5KMA>VL]L)V5KNPIY8,W9UVEDA\X^9IB84]''JI24\JNG/9MB-XW4V#
MSFLB"$5NB[OH'W@:XL-V-/B_QDXGOTFD0VO#\G!=?@'CQZ[>TRW18< 0D0M/B6\%O82,G/0EOHCS3&4?:%N37M"V)'V@
M'0]Y0=L6XP/M.DP?^N]0X)V9@./J$G_684[_Z,IJY#Y?Y):8*Q3#QPXG"OP4
MI]:B"0S%%;6S$G\V8=:>9^F,MIVC2!$!-0G1@WXR1R@\9-$%5#-'DH+(B,1)30HG;N7<\S0>
M(Z<7](H7WZB1PXO =[->0D:&5(&O9KV$C$P! M^!>@D9:< "7X%Z"1DA4D:87.!["S\I(U0N(L$SIY3_ =];;8 -"F5N9'-T7!E+T9O;G0O4W5B='EP92]47!E+T9O;G1$97-C?%GC ?G0$$>HD0U(9.*:HH.NH1@C1%2!*XZJJB1AJC-)J*X\
MB:<&6@G45$B)6!WI4B'62,)N'%($VW%UQ(+D&),>&^6F)(^="BY>$!MLR)/S
M'GD!L4$>>"$@#[R(LCQX,2 /O JEA%QVJ+5P;#^ 5\<,10=00*Z('2!H@)2
MH+20%T,S BH[.2EN+F2WB^1.9+_'Q)F"^)\R75?$D]7](87J7E]1O>OS,8P!DSS12B
M!J6P4E@IHA11BBA%E")*$:6(4D0IHA11BE>*5XI7BE>*5XI7BE>*5XI7BE=*
M4$I02I@H#[3OUD%W[H:4;OM^+&[[3;IJ7_/Q)O<174S=]#0?=/+,]"^AF(.G
MU^E]O$P?Y/;H"["Z?DS%=;Z<=T]?@SND/O;OQ2(MQ^)':I_2H/=9\WG_L]NL
MN[1X;O,.\\2W#H1V7/?=?CR,Z]\M;J;1KWYX>>S[E^*L7^ZVV-,T\_:%.P-"F5N9'-TF4@-34O5UL@,2 T
M(#)=("]2;V]T(#$@,"!2+TEN9F\@.2 P(%(O241;/#,U-39%,3A&048V-31!
M-$8X04(Y0C P,D1"-CDW-3%"/CPS-34V13$X1D%&-C4T031&.$%".4(P,#)$
M0C8Y-S4Q0CY=("]&:6QT97(O1FQA=&5$96-O9&4O3&5N9W1H(#$T,SX^#0IS
M=')E86T-"GB<-=#'$<)0#$51?9.=\#K+G^(? #N)P]$#0IE;F1S=')E86T-"F5N9&]B:@T*>')E9@T*," U
M-@T*,# P,# P,# Q," V-34S-2!F#0HP,# P,# P,#$W(# P,# P(&X-"C P
M,# P,# Q,C4@,# P,# @;@T*,# P,# P,#$X,2 P,# P,"!N#0HP,# P,# P
M-#(P(# P,# P(&X-"C P,# P,#(W,#(@,# P,# @;@T*,# P,# P,C@X," P
M,# P,"!N#0HP,# P,# S,3(S(# P,# P(&X-"C P,# P,#,R.38@,# P,# @
M;@T*,# P,# P,S4S-" P,# P,"!N#0HP,# P,# P,#$Q(#8U-3,U(&8-"C P
M,# P,# P,3(@-C4U,S4@9@T*,# P,# P,# Q,R V-34S-2!F#0HP,# P,# P
M,#$T(#8U-3,U(&8-"C P,# P,# P,34@-C4U,S4@9@T*,# P,# P,# Q-B V
M-34S-2!F#0HP,# P,# P,#$W(#8U-3,U(&8-"C P,# P,# P,3@@-C4U,S4@
M9@T*,# P,# P,# Q.2 V-34S-2!F#0HP,# P,# P,#(P(#8U-3,U(&8-"C P
M,# P,# P,C$@-C4U,S4@9@T*,# P,# P,# R,B V-34S-2!F#0HP,# P,# P
M,#(S(#8U-3,U(&8-"C P,# P,# P,C0@-C4U,S4@9@T*,# P,# P,# R-2 V
M-34S-2!F#0HP,# P,# P,#(V(#8U-3,U(&8-"C P,# P,# P,C<@-C4U,S4@
M9@T*,# P,# P,# R." V-34S-2!F#0HP,# P,# P,#(Y(#8U-3,U(&8-"C P
M,# P,# P,S @-C4U,S4@9@T*,# P,# P,# S,2 V-34S-2!F#0HP,# P,# P
M,#,R(#8U-3,U(&8-"C P,# P,# P,S,@-C4U,S4@9@T*,# P,# P,# S-" V
M-34S-2!F#0HP,# P,# P,#,U(#8U-3,U(&8-"C P,# P,# P,S8@-C4U,S4@
M9@T*,# P,# P,# S-R V-34S-2!F#0HP,# P,# P,#,X(#8U-3,U(&8-"C P
M,# P,# P,SD@-C4U,S4@9@T*,# P,# P,# T," V-34S-2!F#0HP,# P,# P
M,#0Q(#8U-3,U(&8-"C P,# P,# P-#(@-C4U,S4@9@T*,# P,# P,# T,R V
M-34S-2!F#0HP,# P,# P,#0T(#8U-3,U(&8-"C P,# P,# P-#4@-C4U,S4@
M9@T*,# P,# P,# T-B V-34S-2!F#0HP,# P,# P,#0W(#8U-3,U(&8-"C P
M,# P,# P-#@@-C4U,S4@9@T*,# P,# P,# T.2 V-34S-2!F#0HP,# P,# P
M,#4P(#8U-3,U(&8-"C P,# P,# P-3$@-C4U,S4@9@T*,# P,# P,# U,B V
M-34S-2!F#0HP,# P,# P,# P(#8U-3,U(&8-"C P,# P,#0T.3,@,# P,# @
M;@T*,# P,# P-#F4@-38O4F]O=" Q(# @4B]);F9O(#D@,"!2+TE$6SPS
M-34V13$X1D%&-C4T031&.$%".4(P,#)$0C8Y-S4Q0CX\,S4U-D4Q.$9!1C8U
M-$$T1CA!0CE",# R1$(V.3')E9@T*," P#0IT